AbbVie CEO Upbeat On Skyrizi Commercialization, Raises Financial Guidance

 
• By John Davis
  
Steps
Product approvals and increasing revenues are buoying AbbVie, but biosimilar concerns with Humira remain • Source: Shutterstock

More from Business

More from Scrip